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Mutation Reports in the JID 
Beginning this month, The Joumal of Investigative Dermatology will 
contain a new section, entitled "Mutation Reports." In this section 
you will find short articles reporting new mutations found for skin 
diseases. This month the section features two articles reporting new 
mutations for Epidermolysis Bullosa (EB) and one reporting muta-
tions for epidermolytic palmoplantar keratoderma (EPPK). Vail1y et 
al (p. 434) identify a homozygous exon-skipping mutation in the 
laminin 5 gene in a family with the Herlitz type of junctional EB. 
In dystrophic EB, Christiano et al (p. 438) describe a mutation in the 
type VII collagen gene that results in the formation of structurally 
abnormal anchoring fibrils. Rothnagel et al (p. 430) identify several 
mutations in the lA domain of the keratin 9 gene in patients with 
EPPK. 
Error-Prone Replication in Development of Skin Cancer 
In this issue, Quinn et al (p. 309) report that defective DNA 
replication may contribute to skin cancer. To date, most studies of 
the genetic basis of human cancer, including skin cancer, have 
concentrated on the roles of oncogenes and tumor suppressor 
genes. Recently, microsatellite markers, developed for linkage 
analysis and used to detect chromosome loss in tumor samples, have 
led to the identification of a novel genetic a1teration in some human 
tumors. Microsatellites are short repetitive DNA sequences distrib-
uted throughout the genome, which normal cells accurately repli-
cate. However, sebaceous gland tumors from patients with hered-
itary Muir-Torre syndrome show a1terations in the repeat length at 
mu1tiple loci, indicating microsatellite instability secondary to 
replication errors (RER). To determine whether RER occurs in 
other skin tumors from patients with familial cancer syndromes 
associated with RER, Quinn and colleagues examined actinic 
keratoses from a patient belonging to a kindred with Muir Torre 
syndrome and found that RER occurred in tumors other than 
sebaceous neoplasms. In addition, they examined a series of non-
melanoma and melanoma tumors from patients without Muir-
Torre syndrome and found less than 5% of the tumors contained 
RER. The low frequency ofRER suggests that this phenomenon is 
uncommon in most patients with skin cancer. However, the 
identification of RER in some tumors suggests that for some 
patients error-prone replication may be important in the develop-
ment of skin cancer. 
A Gene Therapy Approach that Inhibits Melanoma Growth 
The incidence of melanomas is increasing, and it is estimated that 
by the year 2000 in the United States, 1 in 90 people will develop 
melanoma skin cancer. In this issue, Bonnekoh et al (p. 313) present 
an adenoviral gene therapy that reduces the volume of melanoma 
tumors in nude mice. Because melanoma tumors metastasize and 
resist chemotherapeutic regimes, current treatment is not very 
effective. Bonnekoh and co-workers developed a treatment strategy 
that employed somatic gene therapy techniques. Initially, they 
established melanoma tumors subcutaneously in nude mice. Then 
they transduced these tumors by injecting a recombinant replica-
tion-defective adenovirus containing the herpes simplex virus 
thymidine kinase (HSV -tk) gene. This made the cells sensitive to 
killing by low doses of ganciclovir (GCV). GCV is a non-toxic drug 
that is phosphorylated by HSV -tk and converted to an intermediate 
that inhibits DNA synthesis, thereby killing dividing cells. In addition, 
they found that not all tumor cells must be transduced to see an effect 
because transduced cells release phosphorylated GCV, creating a 
significant "bystander effect," resulting in a 40-50oA, reduction in 
tumor volume in the treated mice. Thus. for rapidly growing solid 
tumors such as melanomas, this is a very suitable approach. 
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Dermal Fibroblasts May Be a Source of TNF 
de Kossodo and co-workers (p. 318) report that after ultraviolet B 
(UVB) irradiation of mice carrying a transgene for tumor necrosis 
factor (TNF), they detect markedly more TNF in the dermis than 
in the epidermis. TNF is an essential mediator of inflammatory and 
immunologic reactions and may also be responsible for the sup-
pressive influence of UVB in contact hypersensitivity. It is secreted 
by many cell types, including keratinocytes stimulated by lipopoly-
saccharide (LPS) or UVB. The development of transgenic mice 
carrying a chloramphenicol acetyl transferase (CAT) reporter with 
the TNF promoter has allowed examination of the conditions that 
cause TNF gene activation. Using these mice, de Kossodo and 
colleagues tested the effects of different wavelengths of UV radia-
tion on TNF production. Their results indicate that low doses of 
UVB can induce TNF synthesis in exposed skin. Because UVB 
generally does not penetrate the dermis, they expected the activity 
to be in the epidermis but, to their surprise, they found that almost 
all of activity was in the dermis. This suggests that a small dose of 
UVB actually penetrates the dermis and directly activates the 
dermal fibroblasts. In support of this theory, they show that a very 
small dose of UVB can induce cultured fibroblasts to express the 
CAT reporter, and irradiation of the transgenic mice with UVC, 
which is absorbed almost entirely in the epidermis, results in CAT 
expression only in the epidermis. Thus, dermal fibroblasts appear to 
produce TNF as a direct result of UVB irradiation. 
A New System to Analyze Autoantibody Reaction with Desmoglein-l 
Emery and colleagues (p. 323) have developed a eukaryotic system 
in which desmoglein-l is appropriately expressed on an epithelial 
cell surface, and they have used this system to demonstrate that sera 
from patients with pemphigus foliaceus (PF) and pemphigus vul-
garis (PV) react with the extracellular domain of desmoglein-l. 
Clinically and histologically, PF and PV show blister formation. 
Several findings have previously suggested that epidermal cell 
detachment may be due to binding of autoantibodies to the cell 
surface, thereby impairing the function of a keratinocyte adhesion 
molecule. Although the exact targets of such autoantibodies have 
not been completely defined, it has been shown that sera from PF 
patients bind to desmoglein-l, a member of the cadherin family. 
Emery et at developed a system for identifying and characterizing 
the epitopes on desmoglein-l that are recognized by the pathogenic 
autoantibodies produced by PF patients. Their approach was to use 
a mammalian epithelial cell line, the COS-l expression system, and 
generate a recombinant form of desmoglein-l, which was ex-
pressed on the COS-l cell surface in the appropriate transmem-
brane orientation. They then used this system to test reactivity of 
sera from PF and PV patients and found that 100% of PF sera 
samples and 55% of PV samples contained autoantibodies against 
the desmoglein-l ectodomain. The COS/ desmoglein-l transfec-
tant expression system described here may prove useful in further 
defining the pathogenically relevant epitopes of desmoglein-1. 
Langerhans Cell Major Histocompatibility Complex Genes Are Regulated Differently from Dendritic 
Cell Major Histocompatibility Complex Genes 
In this issue, Longley et aT (p. 329) report that in mouse Langerhans 
cells, genes for the class II major histocompatibility complex (MHC 
in human, irnmune-response-associated [Ia] antigen in mouse) are 
regulated differently from those in splenic dendritic cells. The 
expression of MHC genes results in cell surface glycoproteins that 
interact with antigenic peptides to form complexes recognized by T 
cells. In the mouse, la antigens (I-E and I-A) are co-expressed on 
thymic epithelia and other cells, including dendritic and Langerhans 
cells. Surface expression of these Ia molecules is regulated and 
controls the diverse in1mune processes requiring CD4+ T cells. 
Langerhans cells are a type of Ia + dendritic cell found in the 
epidermis, where they process antigen in a function associated with 
synthesis of an immune response. To understand the differences 
between Langerhans cell regulation and that of other dendritic 
cells, Longley and co-workers made a series of transgenic mice 
containing EO' gene constructs with promoter region deletions. 
Using immunoperoxidase and immunofluorescence techniques to 
detect antigen on the cell surface, they identified specific regions in 
the 5' flanking sequences of the EO' gene that decrease expression of 
I-E on Langerhans cells, but enable I-E expression by splenic 
dendritic cells. This differential regulation of the inm1Une response 
in Langerhans cells and splenic dendritic cells may be crucial to 
directing the immune response to specific antigens. 
Human Keratinocytes Do Not Produce IL-3 
In this issue, Kondo et at (p. 335) report that human keratinocytes 
do not express interleukin-3 (IL-3) mRNA or protein, even after 
ultraviolet irradiation. IL 3 was originally described as a colony-
forming stimulating factor released from T cells and capable of 
stimulating splenic lymphocytes . The human IL-3 has been mapped 
to chromosome 5 and is closely associated with the granulocyte 
macrophage/colony-stimulating factor (GM-CSF) gene. Although 
T cells are the major source of IL-3, it is also produced by other 
activated cells. It was thought to be produced in keratinocytes 
because the medium from cultured keratinocytes stimulates prolif-
eration ofIL-3-sensitive cells. However, using two highly sensitive 
methods, reverse-transcription polymerase chain reaction (R T-
PCR) and enzyme linked immunosorbent assay (ELISA), Kondo 
and co-workers detected no IL-3 mRNA or protein in keratino-
cytes cultured from human foreskin. Because UVB radiation has 
been shown to upregulate many cytokines, they reasoned that UVB 
may stimulate the keratinocytes to produce IL-3. Again, they found 
110 IL-3 protein secreted into the culture medium. However, when 
the medium was incubated with antibody to GM-CSF, it lost 90% 
of its activity; and antibodies to both GM-CSF and IL-6 obliterated 
all activity. Thus, the IL-3-like activity in cultured human kerati-
nocytes is probably due to the presence of GM-CSF and IL-6. 
